Ontology highlight
ABSTRACT: Objective
To evaluate the efficacy and safety of intratympanic AM-101 in patients with persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden sensorineural hearing loss (ISSNHL), or acute otitis media.Study design
Prospective, double-blind, randomized, placebo-controlled study with follow-up visits on Days 7, 30, and 90.Setting
Twenty-eight European sites (academic tertiary referral centers and private ENT practices).Patients
248 patients aged 16 to 65 years.Interventions
Three intratympanic injections of AM-101 (0.27 or 0.81 mg/ml) or placebo over 3 consecutive days.Main outcome measures
Efficacy was assessed by changes in minimum masking level (MML; primary end point), loudness match, tinnitus loudness, tinnitus
SUBMITTER: van de Heyning P
PROVIDER: S-EPMC3966923 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature